Ms. Ryan joined Nukk-Freeman & Cerra in 2007, bringing extensive experience litigating complex matters in state and federal court both in and outside the tri-state area. Through her prior firm, Ms. Ryan was seconded to a large pharmaceutical company, providing in-house assistance on a variety of transactional and litigation matters. She has experience negotiating and drafting a variety of contractual arrangements, including clinical trial agreements, and providing assistance with respect to employment, product liability, and environmental litigation matters. At Nukk-Freeman & Cerra, Ms. Ryan’s practice focuses on employment litigation, where she develops and executes litigation strategies with respect to employment claims arising under state and federal law. Ms. Ryan represents management exclusively on matters including, but not limited to, discrimination, sexual harassment, retaliation, FMLA and wage and hour issues. Ms. Ryan also has experience before administrative agencies (including state and federal EEO agencies and the DOL).
Listed in Super Lawyers®, Employment and Labor, 2013 – 2019
Listed in Super Lawyers® as a “Rising Star”, Personal Injury Defense: Products, 2007
Healthcare Businesswomen’s Association “Rising Star”, 2003
The Super Lawyers® list is issued by Thomson Reuters. A description of the selection methodology can be found at http://www.superlawyers.com/about/selection_process.html. No aspect of this advertisement has been approved by the Supreme Court of New Jersey.
|Honorable Alfred J. Lechner
United States District Court, District of New Jersey
|1996 - 1997|
|Gibbons P.C., Newark, New Jersey
|2006 - 2007|
|Gibbons P.C., Newark, New Jersey
|1997 - 2006|
|Seton Hall University School of Law
J.D., magna cum laude
Director, Moot Court Board
B.A., English, cum laude
Minor in Business
|State of New Jersey||1996|
|United States District Court, District of New Jersey||1996|
|U.S. Court of Appeals, Third Circuit||1996|
“State Mandated Paid Family Leave Is On the Rise”, NAMWOLF Newsletter, January 2017
“The FDA’s Enhanced Post-Marketing Safety Surveillance Authority Under The Food and Drug Administration (FDA) Amendments Act of 2007: A Litigation Sword or Shield?”, Pharma Advisor, co-authored by Diane E. Lifton, October 9, 2007
“Respond to New Mass Tort Litigation With a Global Strategy”, New Jersey Law Journal, co-authored by Diane E. Lifton, January 29, 2001
By clicking this button and submitting information to us, you will be submitting certain personally identifiable information, or information which used together with other information, can be used to identify you and/or identify information about you, to Nukk-Freeman & Cerra, PC (“NFC”). Such information may be used by NFC to contact or identify you. Personally identifiable information may include, but is not limited to, your [name, phone number, address and/or] email address. We collect this information for the purpose of providing services, identifying and communicating with you, responding to your requests/inquiries, and improving our services. We may use your personally identifiable Information to contact you with time sensitive employment law e-alerts, marketing or promotional offers, invitations to complimentary and informational webinars and seminars, and other information that may be of interest to you. However, by providing any of the foregoing information to you, we are not creating an attorney-client relationship between you and NFC: nor are we providing legal advice to you. You may opt out of receiving any, or all, of these communications from us by following the unsubscribe link in any email we send. However, this will not unsubscribe you from receiving future communications from us which are based upon an independent request, relationship or act by you.